Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Bone strength depends on more than density, because microarchitecture, meaning the thickness, connectivity, and porosity of the internal bone scaffolding, often explains why some people fracture despite normal DXA results. High-resolution imaging such as HR-pQCT and the trabecular bone score measures that internal structure, and studies show these measures predict fragility fractures independently of bone mineral density alone. There are several important factors that change how these scan results should be interpreted, including age, hormones, medications, and prior fracture history, so see below to understand more. Because early bone loss is silent and risk accumulates quietly for years, a free, instant, online symptom check can help you organize your symptoms and risk factors in just a few minutes. That gives you a clearer starting point, and practical next steps to raise with a clinician, ideally before a first fracture ever happens.
Last reviewed for medical accuracy: 08/18/2026
Our bones do more than support us—they adapt, repair, and remodel throughout life. Traditionally, bone mineral density (BMD) measured by DXA scans has guided fracture risk assessment. However, BMD captures only mineral content, not the internal structure that makes bones tough yet resilient. Enter microarchitecture scans, including the Trabecular Bone Score (TBS), which reveal the “quality” of bone beyond density alone.
Bone microarchitecture refers to the internal arrangement of bone tissue at the microscopic level. Two major compartments contribute to strength:
A healthy trabecular network is like a well-built scaffold, whereas deterioration can leave bones brittle and prone to fracture, even if BMD appears near normal.
The Trabecular Bone Score (TBS) is a software-based tool that analyzes texture patterns in standard lumbar spine DXA images. By assessing pixel variations, TBS estimates trabecular microarchitecture quality:
How it works
Key advantages
• No extra radiation or scan time beyond a regular DXA
• Retrospective analysis of existing images
• Cost-effective adjunct to BMD
Proper trabecular bone score TBS scan interpretation helps clinicians refine fracture risk assessment:
| TBS Value Range | Interpretation | Relative Fracture Risk |
|---|
1.350 | Normal microarchitecture | Lower risk 1.200 – 1.350 | Partially degraded | Intermediate risk < 1.200 | Degraded microarchitecture | Higher risk
While TBS is popular for its accessibility, other modalities offer direct assessment:
Each technique has trade-offs in resolution, radiation, cost, and accessibility. In routine practice, TBS stands out for its ease of integration with DXA.
Fracture risk calculators like FRAX® estimate 10-year risk using age, BMD, and clinical factors. Integrating TBS refines these predictions:
Studies show that adding TBS to FRAX® improves identification of individuals who later sustain fractures, especially in cases where BMD is not frankly osteoporotic.
Consider trabecular bone score TBS scan interpretation in:
No single test tells the whole story. Keep in mind:
Whether your TBS is normal or indicates microarchitectural concerns, proactive steps can help maintain or improve bone health:
Changes in bone health can be gradual and silent. If you experience persistent back pain, height loss, or fractures from minor falls, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to gauge whether you should seek in-person evaluation. Always speak to a doctor about anything that could be life threatening or serious.
Bone strength hinges not only on mineral density but also on the microscopic architecture that gives bones resilience. The Trabecular Bone Score offers an accessible window into trabecular health, refining fracture risk assessment and guiding personalized care. By combining BMD, TBS, clinical risk factors, and healthy lifestyle choices, you and your healthcare provider can form a comprehensive strategy to protect bone health and reduce the chance of debilitating fractures.
Remember: interpreting your trabecular bone score TBS scan interpretation within the broader clinical picture is key. Discuss results, concerns, and management options with your doctor to ensure a plan tailored to your needs.
(References)
* Roux C, Briot K. Imminent fracture risk. Osteoporos Int. 2017 Jun;28(6):1765-1769. doi: 10.1007/s00198-017-3976-5. Epub 2017 Feb 24. PMID: 28236126.
* Khosla S, Samakkarnthai P, Monroe DG, Farr JN. Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus. Nat Rev Endocrinol. 2021 Nov;17(11):685-697. doi: 10.1038/s41574-021-00555-5. Epub 2021 Sep 13. PMID: 34518671; PMCID: PMC8605611.
* Martel D, Monga A, Chang G. Osteoporosis Imaging. Radiol Clin North Am. 2022 Jul;60(4):537-545. doi: 10.1016/j.rcl.2022.02.003. Epub 2022 May 20. PMID: 35672087.
* Wu B, Fu Z, Wang X, Zhou P, Yang Q, Jiang Y, Zhu D. A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment. Front Endocrinol (Lausanne). 2022;13:1052592. doi: 10.3389/fendo.2022.1052592. Epub 2022 Dec 14. PMID: 36589835; PMCID: PMC9794857.
* Schini M, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey EV. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis. J Endocrinol Invest. 2024 Mar;47(3):501-511. doi: 10.1007/s40618-023-02219-9. Epub 2023 Oct 24. PMID: 37874461; PMCID: PMC10904566.
* Martiniakova M, Biro R, Penzes N, Sarocka A, Kovacova V, Mondockova V, Omelka R. Links among Obesity, Type 2 Diabetes Mellitus, and Osteoporosis: Bone as a Target. Int J Mol Sci. 2024 Apr 28;25(9). doi: 10.3390/ijms25094827. Epub 2024 Apr 28. PMID: 38732046; PMCID: PMC11084398.
* Zoulakis M, Johansson L, Litsne H, Axelsson K, Lorentzon M. Type 2 Diabetes and Fracture Risk in Older Women. JAMA Netw Open. 2024 Aug 1;7(8):e2425106. doi: 10.1001/jamanetworkopen.2024.25106. Epub 2024 Aug 1. PMID: 39106069; PMCID: PMC11304123.
* Veronese N, Briot K, Guañabens N, Albergaria BH, Alokail M, Al-Daghri N, Bemden AB, Bruyère O, Burlet N, Cooper C, Curtis EM, Ebeling PR, Halbout P, Hesse E, Hiligsmann M, Camargos BM, Harvey NC, Perez AD, Radermecker RP, Reginster JY, Rizzoli R, Siggelkow H, Cortet B, Brandi ML. Recommendations for the optimal use of bone forming agents in osteoporosis. Aging Clin Exp Res. 2024 Aug 9;36(1):167. doi: 10.1007/s40520-024-02826-3. Epub 2024 Aug 9. PMID: 39120740; PMCID: PMC11315730.
* Klemm P, Schulz N, Lange U, Bühring B. [Diagnostics and treatment of osteoporosis in 2025 : An update on current guidelines]. Inn Med (Heidelb). 2025 Jun;66(6):603-614. doi: 10.1007/s00108-025-01884-7. Epub 2025 May 16. PMID: 40377675.
* Hofbauer LC, Compston JE, Saag KG, Rauner M, Tsourdi E. Glucocorticoid-induced osteoporosis: novel concepts and clinical implications. Lancet Diabetes Endocrinol. 2025 Nov;13(11):964-979. doi: 10.1016/S2213-8587(25)00251-7. Epub 2025 Sep 26. PMID: 41022095.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.